Rep. Paul Gosar Demands Closure of Fauci's Rocky Mountain Lab Amid Virus Smuggling Allegations

The Catalyst

Republican Representative Paul Gosar of Arizona has formally requested that Health and Human Services Secretary Robert F. Kennedy Jr. and National Institutes of Health Director Jayanta Bhattacharya shut down the Rocky Mountain Laboratories in Hamilton, Montana, according to an exclusive report from Breitbart News. The request follows revelations from the White Coat Waste Project (WCW), a nonprofit watchdog organization that investigates government-funded animal experimentation, which exposed what it describes as scandals involving virus smuggling and monkey bite incidents at the facility. The lab, formally known as Rocky Mountain Laboratories (RML), operates as a National Institute of Allergy and Infectious Diseases (NIAID) campus and was formerly under the direct leadership of Dr. Anthony Fauci during his decades-long tenure as NIAID director from 1984 to 2022. Gosar's letter, addressed to both Kennedy and Bhattacharya, cites WCW's findings as the primary justification for immediate closure, arguing that the facility poses ongoing biosafety risks and lacks adequate oversight. The congressman's move represents a significant escalation in congressional scrutiny of federal high-containment laboratories, particularly those associated with controversial pathogen research. Breitbart News reports that Gosar's office confirmed the letter was sent in early July 2026, though the exact date was not specified in the source material. The source does not provide the full text of Gosar's letter or specify whether it was co-signed by other members of Congress. Historically, Rocky Mountain Laboratories has been a key site for research on emerging infectious diseases, including work on coronaviruses, prion diseases, and tick-borne pathogens, operating at Biosafety Level 3 and 4 containment levels. The facility's association with Fauci, who became a polarizing figure during the COVID-19 pandemic, has made it a focal point for critics of gain-of-function research and federal pandemic response policies.

The White Coat Waste Project's allegations, which form the basis of Gosar's request, center on two primary categories of misconduct: virus smuggling and primate safety incidents. According to WCW's public statements and reports referenced by Breitbart, the organization obtained internal documents through Freedom of Information Act requests that allegedly show unauthorized transfer of viral materials and multiple instances of monkey bites involving laboratory staff. The source does not provide specific dates for these alleged incidents, nor does it detail the types of viruses allegedly smuggled, the number of monkey bite incidents, or whether any resulted in infections or exposures requiring medical intervention. WCW has previously targeted other federal research facilities, including the Wisconsin National Primate Research Center and various Department of Veterans Affairs animal labs, often partnering with Republican lawmakers to advance legislative restrictions on animal research. The organization's founder, Anthony Bellotti, has testified before Congress on animal welfare issues and maintains close ties to conservative policymakers. Breitbart's reporting does not indicate whether independent verification of WCW's claims has been conducted by other media outlets, congressional staff, or federal inspectors. The source also does not mention any response from HHS, NIH, or NIAID leadership to Gosar's request at the time of publication. This development occurs against a backdrop of intensified debate over laboratory biosafety standards following the COVID-19 pandemic, with multiple congressional committees, the Government Accountability Office, and the National Science Advisory Board for Biosecurity all reviewing federal research oversight frameworks.

Historical Context

Rocky Mountain Laboratories was established in 1928 as a field station for the U.S. Public Health Service to study Rocky Mountain spotted fever, a tick-borne disease endemic to the Bitterroot Valley of western Montana. The facility became part of the National Institutes of Health in 1932 and was formally designated as a NIAID intramural research campus in 1970. Over its nearly century-long history, RML has been associated with significant scientific achievements, including pioneering work on prion diseases by Dr. Byron Caughey and colleagues, research on tick-borne pathogens such as Lyme disease and relapsing fever, and more recently, coronavirus research including studies on SARS-CoV-1, MERS-CoV, and SARS-CoV-2. The lab's high-containment facilities, including Biosafety Level 4 (BSL-4) laboratories completed in 2008, positioned it as one of a small number of U.S. sites authorized to work with the most dangerous known pathogens. Dr. Anthony Fauci, as NIAID director from 1984 until his retirement in December 2022, had oversight authority over RML's research portfolio, budget, and strategic direction, though day-to-day operations were managed by on-site scientific leadership. During Fauci's tenure, NIAID's budget grew from approximately $320 million in 1984 to over $6.3 billion by 2022, with significant allocations for biodefense and emerging infectious disease research following the 2001 anthrax attacks and subsequent pandemic preparedness initiatives. The laboratory's expansion into BSL-4 capabilities was part of a broader federal investment in high-containment research infrastructure, including similar facilities at Fort Detrick, Maryland; Galveston, Texas; and Atlanta, Georgia (CDC). Historically, RML has maintained a strong safety record in public reports, with no documented laboratory-acquired infections resulting in community transmission in federal biosafety reports published through 2023. However, the facility has faced periodic scrutiny from animal welfare advocates regarding its non-human primate research programs, which utilize rhesus macaques and other species for infectious disease modeling. The White Coat Waste Project, founded in 2013, has made RML a recurring target of its campaigns, alleging wasteful spending and animal cruelty in federally funded research. WCW's previous investigations have led to legislative action, including the 2019 VA puppy research ban and 2021 restrictions on FDA dog testing requirements. The current allegations of virus smuggling and monkey bite incidents represent a significant escalation in WCW's claims against RML, moving beyond animal welfare concerns to direct biosafety and biosecurity accusations. The source does not provide details on whether these allegations have been referred to the NIH Office of Laboratory Safety, the CDC's Division of Select Agents and Toxins, or the Department of Health and Human Services Office of Inspector General for formal investigation.

Stakeholder Positions

Representative Paul Gosar, a Republican from Arizona's 9th congressional district serving since 2011, has positioned himself as a leading congressional critic of federal public health agencies and pandemic-era policies. A dentist by profession, Gosar has consistently voted against COVID-19 relief packages, mask mandates, and vaccine requirements, and was one of 21 House Republicans who voted against the establishment of the January 6th select committee. His letter to Secretary Kennedy and Director Bhattacharya aligns with his broader legislative agenda of reducing federal research spending and increasing oversight of scientific agencies. Gosar serves on the House Committee on Oversight and Accountability and the Committee on Natural Resources, giving him jurisdictional footing for laboratory oversight issues. The source does not indicate whether Gosar has introduced or plans to introduce legislation to mandate RML's closure, or whether he has sought support from House leadership or the Oversight Committee chair for a formal hearing. Health and Human Services Secretary Robert F. Kennedy Jr., confirmed in February 2025, has a well-documented history of skepticism toward federal vaccine programs and pharmaceutical industry influence on regulatory agencies. His appointment represented a significant departure from traditional public health leadership, and his approach to laboratory biosafety oversight remains an open question. Kennedy has previously criticized gain-of-function research and called for moratoriums on certain categories of pathogen enhancement experiments. However, the source does not provide any statement from Kennedy or his office regarding Gosar's request, nor does it indicate whether Kennedy has directed any review of RML operations since assuming office. NIH Director Jayanta Bhattacharya, a Stanford University health policy professor and co-author of the Great Barrington Declaration opposing COVID-19 lockdowns, was confirmed as NIH director in March 2025. Bhattacharya has advocated for reform of NIH grant-making processes and greater transparency in research funding decisions. Like Kennedy, his specific position on RML and high-containment laboratory oversight has not been extensively detailed in public statements since his confirmation. The source does not include any response from Bhattacharya or NIH leadership to Gosar's letter. The White Coat Waste Project, as the source of the allegations driving Gosar's request, represents an advocacy organization with a specific ideological orientation against animal research. WCW's funding comes primarily from conservative donors and foundations, and its board includes former Republican congressional staff. The organization's credibility on biosafety technical matters has been questioned by some research advocacy groups, including the Foundation for Biomedical Research and the National Association for Biomedical Research, which argue that WCW conflates animal welfare concerns with legitimate biosafety issues. The source does not provide WCW's specific evidence documents or indicate whether they have been shared with congressional investigators or federal inspectors. Former NIAID Director Anthony Fauci, now retired from federal service, has not issued a public statement on Gosar's request according to the source. Fauci has previously defended NIAID's research portfolio and oversight mechanisms during congressional testimony in 2021-2023, maintaining that gain-of-function research definitions were mischaracterized by critics and that NIH-funded work at Wuhan Institute of Virology did not meet the regulatory definition of gain-of-function. The Rocky Mountain Laboratories scientific staff and leadership, including current director Dr. Marshall Bloom (who has led the facility since 2002), have not been quoted in the source material responding to the allegations or the closure request.

Mechanics & Evidence

The evidentiary basis for Gosar's closure request rests primarily on the White Coat Waste Project's investigative findings, which Breitbart News describes as exposing "scandals including virus smuggling as well as monkey bite incidents." The source does not provide primary documentation, specific incident reports, or detailed evidentiary records from WCW's investigation. According to WCW's public methodology, the organization typically obtains records through Freedom of Information Act (FOIA) requests to federal agencies, state open records laws, and occasionally through whistleblower disclosures. WCW then publishes reports, often accompanied by selected document excerpts, on its website and distributes them to allied media outlets and congressional offices. The source does not specify which FOIA requests yielded the alleged evidence, which agencies responded (NIH, CDC, USDA APHIS, or others), or the timeframe covered by the obtained records. Regarding the virus smuggling allegation, the term "smuggling" in a laboratory context typically refers to unauthorized transfer of select agents or toxins regulated under 42 CFR Part 73 (HHS select agent regulations) or 7 CFR Part 331 / 9 CFR Part 121 (USDA select agent regulations), or violations of Material Transfer Agreements (MTAs) governing pathogen sharing between institutions. Federal select agent regulations require registration of all entities and individuals possessing, using, or transferring select agents, with mandatory reporting of any theft, loss, or release within 24 hours. Violations can result in civil penalties up to $300,000 per violation and criminal penalties including fines and imprisonment. The source does not specify whether WCW's allegations involve select agents, non-select agent pathogens, or whether any transfers crossed international borders, which would implicate additional export control regulations under the Commerce Control List and International Traffic in Arms Regulations. Regarding monkey bite incidents, non-human primate research facilities are required to maintain occupational health programs under NIH Guidelines, OSHA standards, and AAALAC accreditation requirements. Macaque bites carry specific risks including B virus (Macacine herpesvirus 1) exposure, which requires immediate post-exposure prophylaxis and monitoring. Facilities must report certain incidents to NIH's Office of Laboratory Animal Welfare (OLAW) and USDA under the Animal Welfare Act. The source does not provide the number of alleged bite incidents, the timeframe, whether they were reported through required channels, whether any resulted in B virus exposure or other infections, or whether USDA inspection reports cited violations. The source also does not indicate whether WCW's findings have been corroborated by USDA Animal and Plant Health Inspection Service (APHIS) inspection reports, which are publicly available for research facilities, or by NIH's Division of Occupational Health and Safety reviews. Breitbart News' exclusive report does not include independent verification of WCW's claims, nor does it reference any congressional staff review of the underlying documents. The article does not mention whether Gosar's office conducted its own due diligence before sending the letter, or whether the letter requests specific investigative actions (GAO audit, HHS OIG investigation, congressional hearing) in addition to or instead of immediate closure. The absence of primary evidence in the source material significantly limits the ability to assess the credibility and severity of the allegations. Historically, similar allegations against federal laboratories have resulted in temporary suspensions of specific research protocols, personnel actions, or facility upgrades rather than complete laboratory closures, which would require extensive decommissioning procedures for BSL-4 facilities and relocation of research programs.

What Happens Next

Several concrete next steps are likely to unfold in the coming weeks and months based on standard congressional and federal agency processes. First, HHS and NIH leadership must formally receive and log Gosar's letter, which typically triggers a congressional correspondence tracking process with a standard 30-60 day response deadline. Secretary Kennedy and Director Bhattacharya will likely assign staff to review the allegations and prepare a formal response, which may include a commitment to investigate, a request for additional information from WCW or Gosar's office, or a defense of RML's safety record citing recent inspection results. The source does not indicate whether Gosar has simultaneously contacted the House Committee on Oversight and Accountability (chaired by Rep. James Comer, R-KY) or the House Energy and Commerce Committee (which has jurisdiction over NIH) to request a formal hearing or investigation. Given Gosar's membership on the Oversight Committee, he may pursue a committee-level inquiry, which could include document requests to HHS, NIH, and WCW, transcribed interviews with RML leadership and safety officers, and potentially a public hearing. Historically, such investigations take 6-18 months to produce public reports. Second, WCW will likely publish its full investigative report with supporting documents, which would allow independent assessment of the evidence. WCW typically coordinates report releases with allied media and congressional offices for maximum impact. The timing of such a release is not specified in the source. Third, USDA APHIS may conduct an unannounced inspection of RML's animal facilities if the monkey bite allegations involve potential Animal Welfare Act violations. USDA inspection reports are typically posted within 30-60 days of inspection. Fourth, if the virus smuggling allegations involve select agents, the CDC's Division of Select Agents and Toxins (DSAT) and/or USDA's Agricultural Select Agent Services would have jurisdiction to investigate. Select agent violations can result in suspension of a facility's registration, effectively halting all select agent research. The source does not indicate whether any such referral has been made. Fifth, the NIH Office of Laboratory Safety and the institutional biosafety committee (IBC) at RML would conduct internal reviews of any alleged incidents. BSL-4 facilities undergo periodic reviews. Sixth, the broader political context suggests this issue may be incorporated into the FY2027 appropriations process, where House Republicans could attach riders restricting funding for RML or mandating specific oversight reforms. The Labor-HHS-Education appropriations bill, which funds NIH, is typically marked up in spring/summer 2026 for the fiscal year beginning October 1, 2026. Seventh, research advocacy organizations (FBR, NABR, AAAS, Association of American Medical Colleges) will likely mobilize to defend RML's scientific contributions and argue that closure would damage national pandemic preparedness capabilities. The source does not provide information on RML's current research portfolio, funding levels, or staffing, which would be relevant to assessing closure impact. Eighth, if the allegations are substantiated, the most probable outcome is not immediate closure but rather targeted corrective actions: suspension of specific protocols, personnel disciplinary actions, enhanced training, facility upgrades, and increased inspection frequency. Complete decommissioning of a BSL-4 facility is a multi-year process costing tens of millions of dollars and requiring relocation of research programs to other high-containment facilities, of which there are limited alternatives in the U.S. The source does not provide any timeline or process details from Gosar's letter regarding how closure would be implemented.

The Bottom Line

Representative Paul Gosar's request to close Rocky Mountain Laboratories represents a significant political escalation in the ongoing debate over federal high-containment laboratory oversight, but the evidentiary foundation for the demand remains opaque in the public record. The Breitbart News exclusive report provides only a summary of Gosar's letter and a characterization of White Coat Waste Project's allegations without primary documentation, specific incident details, or independent verification. This information gap is critical: allegations of "virus smuggling" and "monkey bite incidents" encompass a wide spectrum of potential severity, from minor procedural violations with no safety consequences to serious breaches of select agent regulations and occupational health failures. Without access to WCW's underlying FOIA documents, USDA inspection reports, NIH safety reviews, or congressional staff analysis, it is impossible to assess whether the allegations warrant the extraordinary remedy of shutting down a major federal BSL-4 facility. The source does not provide details on RML's current research portfolio, which includes work on priority pathogens identified by WHO and NIH as posing pandemic threats, nor does it address the operational consequences of closure for national biodefense capabilities. The political dynamics are clear: Gosar, Kennedy, and Bhattacharya share a critical orientation toward establishment public health institutions, and WCW is an ideologically aligned advocacy group with a track record of targeting animal research. This alignment increases the probability of formal investigative action but also raises questions about whether the allegations are being evaluated through a rigorous evidence-based framework or a predetermined policy conclusion. For readers, the key takeaway is that a congressional closure demand has been made based on watchdog allegations, but the specific evidence remains unpublished and unverified by independent parties. The next meaningful developments will be: (1) WCW's publication of its full report with primary documents, (2) HHS/NIH's formal response to Gosar, (3) any congressional committee action initiated by the Oversight or Energy and Commerce committees, and (4) USDA/CDC regulatory responses if select agent or animal welfare violations are substantiated. Until primary evidence enters the public domain, the story remains a political claim awaiting evidentiary validation. The source does not provide sufficient information to determine the credibility of the allegations or the likelihood of actual laboratory closure versus targeted corrective actions.